DENTSPLY SIRONA
Market Cap
US$9.5b
Last Updated
2020/08/06 23:45 UTC
Data Sources
Company Financials +
Executive Summary
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental products and technologies, and other consumable dental products and equipment primarily for the professional dental market worldwide.
Rewards
Risk Analysis
Snowflake Analysis
Excellent balance sheet and fair value.
Similar Companies
Share Price & News
How has DENTSPLY SIRONA's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: XRAY has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-4.4%
XRAY
-0.2%
US Medical Equipment
3.0%
US Market
1 Year Return
-17.4%
XRAY
14.8%
US Medical Equipment
15.8%
US Market
Return vs Industry: XRAY underperformed the US Medical Equipment industry which returned 16.8% over the past year.
Return vs Market: XRAY underperformed the US Market which returned 15.4% over the past year.
Shareholder returns
| XRAY | Industry | Market | |
|---|---|---|---|
| 7 Day | -4.4% | -0.2% | 3.0% |
| 30 Day | -0.3% | 8.5% | 6.0% |
| 90 Day | 6.4% | 10.7% | 16.4% |
| 1 Year | -16.7%-17.4% | 15.8%14.8% | 18.4%15.8% |
| 3 Year | -20.2%-22.1% | 75.5%70.7% | 44.8%35.4% |
| 5 Year | -21.5%-24.1% | 118.0%101.1% | 75.7%56.7% |
Price Volatility Vs. Market
How volatile is DENTSPLY SIRONA's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 months ago | Simply Wall St
Are DENTSPLY SIRONA's (NASDAQ:XRAY) Statutory Earnings A Good Reflection Of Its Earnings Potential?3 months ago | Simply Wall St
Are DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Mixed Financials Driving The Negative Sentiment?4 months ago | Simply Wall St
Only 4 Days Left To Cash In On DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) DividendValuation
Is DENTSPLY SIRONA undervalued compared to its fair value and its price relative to the market?
48.1%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: XRAY ($43.26) is trading below our estimate of fair value ($83.38)
Significantly Below Fair Value: XRAY is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: XRAY is poor value based on its PE Ratio (114.9x) compared to the US Medical Equipment industry average (54.5x).
PE vs Market: XRAY is poor value based on its PE Ratio (114.9x) compared to the US market (18.5x).
Price to Earnings Growth Ratio
PEG Ratio: XRAY is poor value based on its PEG Ratio (1.6x)
Price to Book Ratio
PB vs Industry: XRAY is good value based on its PB Ratio (2x) compared to the US Medical Equipment industry average (4.2x).
Next Steps
Future Growth
How is DENTSPLY SIRONA forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
71.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XRAY's forecast earnings growth (71.4% per year) is above the savings rate (2.2%).
Earnings vs Market: XRAY's earnings (71.4% per year) are forecast to grow faster than the US market (22.6% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: XRAY's revenue (8% per year) is forecast to grow slower than the US market (9.4% per year).
High Growth Revenue: XRAY's revenue (8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: XRAY's Return on Equity is forecast to be low in 3 years time (10.3%).
Next Steps
Past Performance
How has DENTSPLY SIRONA performed over the past 5 years?
-28.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: XRAY has a large one-off loss of $383.7M impacting its June 30 2020 financial results.
Growing Profit Margin: XRAY became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: XRAY has become profitable over the past 5 years, growing earnings by -28.8% per year.
Accelerating Growth: XRAY has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: XRAY has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.2%).
Return on Equity
High ROE: XRAY's Return on Equity (1.8%) is considered low.
Next Steps
Financial Health
How is DENTSPLY SIRONA's financial position?
Financial Position Analysis
Short Term Liabilities: XRAY's short term assets ($1.8B) exceed its short term liabilities ($891.5M).
Long Term Liabilities: XRAY's short term assets ($1.8B) do not cover its long term liabilities ($2.5B).
Debt to Equity History and Analysis
Debt Level: XRAY's debt to equity ratio (30.7%) is considered satisfactory.
Reducing Debt: XRAY's debt to equity ratio has reduced from 60.9% to 30.7% over the past 5 years.
Debt Coverage: XRAY's debt is well covered by operating cash flow (41.2%).
Interest Coverage: XRAY's interest payments on its debt are well covered by EBIT (20.5x coverage).
Balance Sheet
Next Steps
Dividend
What is DENTSPLY SIRONA current dividend yield, its reliability and sustainability?
0.92%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: XRAY's dividend (0.92%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.65%).
High Dividend: XRAY's dividend (0.92%) is low compared to the top 25% of dividend payers in the US market (4.45%).
Stability and Growth of Payments
Stable Dividend: XRAY's dividends per share have been stable in the past 10 years.
Growing Dividend: XRAY's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (102.9%), XRAY's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: XRAY's dividends in 3 years are forecast to be thoroughly covered by earnings (14.6% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.9yrs
Average management tenure
CEO
Don Casey (60 yo)
2.5yrs
Tenure
US$11,366,243
Compensation
Mr. Donald M. Casey, Jr., also known as Don, serves as CEO and Director at DENTSPLY International Inc., since 2018. Mr. Casey has been Chief Executive Officer and a Director at Dentsply Sirona Inc. since ...
CEO Compensation Analysis
Compensation vs Market: Don's total compensation ($USD11.37M) is above average for companies of similar size in the US market ($USD7.33M).
Compensation vs Earnings: Don's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.5yrs | US$11.37m | 0.045% $ 4.2m | |
| Executive VP & CFO | 1yr | US$10.30m | 0.0099% $ 942.1k | |
| Executive VP | 2.83yrs | US$4.61m | 0.0076% $ 715.5k | |
| Senior VP & Chief Commercial Officer | 3.08yrs | US$3.11m | 0.021% $ 1.9m | |
| Senior VP & Chief Technology Officer | 1.25yrs | no data | 0.0018% $ 165.9k | |
| Vice President of Investor Relations | no data | no data | no data | |
| Senior VP and Chief HR Officer & Communications | 0.83yr | no data | 0.0017% $ 159.2k | |
| Senior VP | 1.25yrs | no data | 0.0051% $ 480.5k | |
| Senior Vice President | 11.58yrs | US$1.35m | no data | |
| Chief Clinical Officer & VP | no data | no data | no data | |
| Senior Vice President of EMEA RCO | 3.08yrs | US$1.52m | 0.012% $ 1.1m | |
| Senior VP of Business Development & Strategy Officer | 1.25yrs | no data | 0.0082% $ 780.9k |
1.9yrs
Average Tenure
52.5yo
Average Age
Experienced Management: XRAY's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.5yrs | US$11.37m | 0.045% $ 4.2m | |
| Independent Director | 15.25yrs | US$326.95k | 0.012% $ 1.1m | |
| Independent Non-Executive Chairman | 2.92yrs | US$517.03k | 0.013% $ 1.2m | |
| Independent Director | 4.5yrs | US$278.57k | 0.059% $ 5.5m | |
| Independent Director | 2.58yrs | US$321.32k | 0.0042% $ 400.9k | |
| Independent Director | 19.5yrs | US$271.25k | 0.0050% $ 472.0k | |
| Independent Director | 2.58yrs | US$278.75k | no data | |
| Independent Director | 1.25yrs | US$256.42k | 0.0061% $ 576.2k | |
| Independent Director | 4.5yrs | US$267.50k | 0.019% $ 1.8m | |
| Independent Director | 9.5yrs | US$283.75k | 0.0069% $ 656.8k | |
| Independent Director | 0.92yr | US$162.13k | no data |
2.9yrs
Average Tenure
64yo
Average Age
Experienced Board: XRAY's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: XRAY insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
DENTSPLY SIRONA Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: DENTSPLY SIRONA Inc.
- Ticker: XRAY
- Exchange: NasdaqGS
- Founded: 1899
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$9.477b
- Shares outstanding: 219.08m
- Website: https://www.dentsplysirona.com
Number of Employees
Location
- DENTSPLY SIRONA Inc.
- 13320 Ballantyne Corporate Place
- Charlotte
- North Carolina
- 28277-3607
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| XRAY | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Aug 1987 |
| DY2 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Aug 1987 |
| 0I8F | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Aug 1987 |
| XRAY | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Aug 1987 |
| DY2 | ETLX (Eurotlx) | Yes | Common Stock | IT | EUR | Aug 1987 |
| XRAY34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH REP 1 COM USD0.01 | BR | BRL | May 2019 |
Biography
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental products and technologies, and other consumable dental products and equipment primarily for the professional dental market w ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/08/06 23:45 |
| End of Day Share Price | 2020/08/06 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.